SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001789317-22-000002
Filing Date
2022-07-19
Accepted
2022-07-19 16:39:51
Documents
2
Period of Report
2022-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_165826317668769.html 3  
1 FORM 3 wf-form3_165826317668769.xml 3 1722
2 POWER OF ATTORNEY (DRAPPA) alpn-section16powerofattor.htm EX-24 2244
  Complete submission text file 0001789317-22-000002.txt   5560
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VIELA BIO, INC., ONE MEDIMMUNE WAY FIRST FLOOR, AREA TWO GAITHERSBURG MD 20878
Business Address
Drappa Jorn (Reporting) CIK: 0001789317 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37449 | Film No.: 221091954